Your browser doesn't support javascript.
loading
Differential Perspectives by Specialty on Oligometastatic Colorectal Cancer: A Korean Oligometastasis Working Group's Comparative Survey Study.
Cho, Won Kyung; Yoo, Gyu Sang; Rim, Chai Hong; Jeong, Jae-Uk; Chie, Eui Kyu; Ahn, Yong Chan; Cho, Hyeon-Min; Um, Jun Won; Suh, Yang-Gun; Chang, Ah Ram; Lee, Jong Hoon.
Afiliação
  • Cho WK; Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Yoo GS; Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Rim CH; Department of Radiation Oncology, Korea University Ansan Hospital, Korea University College of Medicine, Ansan, Korea.
  • Jeong JU; Department of Radiation Oncology, Chonnam National University Hwasun Hospital, Chonnam National University College of Medicine, Hwasun, Korea.
  • Chie EK; Department of Radiation Oncology, Seoul National University College of Medicine, Seoul, Korea.
  • Ahn YC; Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Cho HM; Department of Surgery, St. Vincent`s Hospital, College of Medicine, The Catholic University of Korea, Suwon, Korea.
  • Um JW; Department of Surgery, Korea University Ansan Hospital, Korea University College of Medicine, Ansan, Korea.
  • Suh YG; Proton Therapy Center, Research Institute and Hospital, National Cancer Center, Goyang, Korea.
  • Chang AR; Department of Radiation Oncology, Soonchunhyang University Seoul Hospital, Seoul, Korea.
  • Lee JH; Department of Radiation Oncology, St Vincent's Hospital, College of Medicine, The Catholic University of Korea, Suwon, Korea.
Cancer Res Treat ; 55(4): 1281-1290, 2023 Oct.
Article em En | MEDLINE | ID: mdl-37290481
PURPOSE: Despite numerous studies on the optimal treatments for oligometastatic disease (OMD), there is no established interdisciplinary consensus on its diagnosis or classification. This survey-based study aimed to analyze the differential opinions of colorectal surgeons and radiation oncologists regarding the definition and treatment of OMD from the colorectal primary. MATERIALS AND METHODS: A total of 141 participants were included in this study, consisting of 63 radiation oncologists (44.7%) and 78 colorectal surgeons (55.3%). The survey consisted of 19 questions related to OMD, and the responses were analyzed using the chi-square test to determine statistical differences between the specialties. RESULTS: The radiation oncologists chose "bone" more frequently compared to the colorectal surgeons (19.2% vs. 36.5%, p=0.022), while colorectal surgeons favored "peritoneal seeding" (26.9% vs. 9.5%, p=0.009). Regarding the number of metastatic tumors, 48.3% of colorectal surgeons responded that "irrelevant, if all metastatic lesions are amendable to local therapy", while only 21.8% of radiation oncologist chose same answer. When asked about molecular diagnosis, most surgeons (74.8%) said it was important, but only 35.8% of radiation oncologists agreed. CONCLUSION: This study demonstrates that although radiation oncologists and colorectal surgeons agreed on a majority of aspects such as diagnostic imaging, biomarker, systemic therapy, and optimal timing of OMD, they also had quite different perspectives on several aspects of OMD. Understanding these differences is crucial to achieving multidisciplinary consensus on the definition and optimal management of OMD.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais Limite: Humans País/Região como assunto: Asia Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais Limite: Humans País/Região como assunto: Asia Idioma: En Ano de publicação: 2023 Tipo de documento: Article